A059.2. Poster board 499 - Sun 09/07, 16:45 - Hall Y
Baccaglioni E. (1, 2), Brambilla L. (3), Magara F. (2), Magistretti P. J. (2) & Volterra A. (1, 2).
(1) DBCM, University of Lausanne, Lausanne, Switzerland; (2) CNP, Hôpital de Cery, Prilly, Switzerland; (3) Dep. Pharmacol. Sci., University of Milan, Milan, Italy
- A PREFRONTAL CORTEX DEFECT OF GLUTAMATE RELEASE CAPACITY IN THE PHENCYCLIDINE (PCP) MODEL OF SCHIZOPHRENIA.
A059.3. Poster board 500 - Sun 09/07, 16:00 - Hall Y
Barbon A. (1), Fumagalli F. (2), La Via L. (1), Racagni G. (2, 3), Riva M. A. (2) & Barlati S. (1).
(1) Dept. Biomedical Sciences, Univ. Brescia, Brescia, Italy; (2) Dept. Pharmacological Sciences, Univ. Milan, Milan, Italy; (3) I. R. C. C. S. San Giovanni di Dio-FBF, Brescia, Italy
- CHRONIC PHENCYCLIDINE ADMINISTRATION REDUCES THE EXPRESSION AND EDITING OF SPECIFIC GLUTAMATE RECEPTORS IN RAT PREFRONTAL CORTEX.
A059.4. Poster board 501 - Sun 09/07, 16:45 - Hall Y
Benzel I. M. (1), Kew J. N. (1), Stevenson H. T. (2) & Maycox P. R. (1)
(1) Psychiatry CEDD, GlaxoSmithKline, Harlow, United Kingdom; (2) Genomics & Proteomic Sciences, GlaxoSmithKline, Stevenage, United Kingdom
- INVESTIGATION OF G72 EXPRESSION IN THE HUMAN BRAIN.
A059.5. Poster board 502 - Sun 09/07, 16:00 - Hall Y
Boucher A. A. (1, 2, 3), Duffy L. (3), Hunt G. E. (4), Micheau J. (1), Hinton T. (2, 3), Karl T. (3, 5) & Arnold J. C. (2, 3)
(1) Lab. de Neurosc. Cognit., Univ. Bordeaux1, 33405, Talence, France; (2) Dept. of Pharmacol., Univ. of Sydney, NSW 2006, Sydney, Australia; (3) Neurosc. Inst. of Schizophrenia and Allied Disord., NSW 2010, Sydney, Australia; (4) Dept. of Psychol. Med., Univ. of Sydney, NSW 2006, Sydney, Australia; (5) Neurobiol. Prog., the Garvan inst. of med. res., NSW 2010, Sydney, Australia
- CANNABIS USE IN AN ANIMAL MODEL FOR SCHIZOPHRENIA - EFFECTS OF ACUTE DELTA9-TETRAHYDROCANNABINOL TREATMENT IN NEUREGULIN1 KNOCKOUT MICE.
A059.6. Poster board 503 - Sun 09/07, 16:45 - Hall Y
Dobrota D. (1), Dragasek J. (2), Bittsansky M. (3), Drimalova M. (2), Polacek H. (3), Hladka M. (3) & Duroska M. (4)
(1) Dept. Med. Biochemistry, JF Med. Comenius Univ., Martin, Slovakia; (2) Dept. Psychiatry, JF Med. Comenius Univ., Martin, Slovakia; (3) Dept. Radiodiagnostics, JF Med. Comenius Univ., Martin, Slovakia; (4) JF Med. Comenius Univ., Martin, Slovakia
- PROTON MAGNETIC RESONANCE SPECTROSCOPY OF THE FRONTAL WHITE MATTER IN PATIENTS WITH SCHIZOPHRENIA.
A059.7. Poster board 504 - Sun 09/07, 16:00 - Hall Y
Ferra A. (1, 3), Morris B. J. (1, 3), Pratt J. A. (1, 2) & Cochran S. M. (1, 2)
(1) Yoshitomi Res Inst for Neurosci, Univ of Glasgow, Glasgow, United Kingdom; (2) Dep of Physiol and Pharmacol, Univ of Strathclyde, Glasgow, United Kingdom; (3) Inst of Biomed and Life Sci, Univ of Glasgow, Glasgow, United Kingdom
- TRANSCRIPTOME ANALYSIS OF LASER-MICRODISSECTED RAT BRAIN REGIONS RELEVANT TO COGNITION AND PSYCHIATRIC DISORDERS.
A059.8. Poster board 505 - Sun 09/07, 16:45 - Hall Y
Frasca A., Fumagalli F., Racagni G. & Riva M. A.
Centre of Neuropharmacology, Dept. Pharmacol Sci., Univ. Milan, Milan, Italy
- ERK 1/2 AND ALFA-CAMKII: TWO NOVEL TARGETS FOR ANTIPSYCHOTIC THERAPY.
A059.9. Poster board 506 - Sun 09/07, 16:00 - Hall Y
Gaspar P. A. (1), Ruiz S. M. (1), Zamorano F. (1), Bosman C. (1, 2), Cosmelli D. (1) & Aboitiz F. (1)
(1) Cognitive neurociences lab., Santiago, Chile; (2) FC. Donders Center, Nijmegen, Netherlands
- BRAIN SYNCHRONY AND ITS RELATIONS WITH WORKING MEMORY IMPAIRMENTS IN SCHIZOPHRENIC PATIENTS.
A059.10. Poster board 507 - Sun 09/07, 16:45 - Hall Y
Graw J. (1), Ganguly K. (1), Favor J. (2), Beckers J. (3), Hölter-Koch S. (1) & Klopstock T. (4)
(1) GSF-National Research Center, Inst. Dev. Genet., Neuherberg, Germany; (2) GSF-National Research Center, Inst. Hum. Genet., Neuherberg, Germany; (3) GSF--National Research Center, Inst. Exp. Genet., Neuherberg, Germany; (4) Ludwig-Maximilian-Univ. Munich, Dept. Neurology, Munich, Germany
- EFFECT OF MUTATED BETA-B2-CRYSTALLIN ON LENS, BRAIN AND BEHAVIOR OF MICE.
A059.11. Poster board 508 - Sun 09/07, 16:00 - Hall Y
Gronier B. & Bennett S.
School of Pharmacy, De Montfort University, Leicester, UK
- LACK OF ACTIVATORY EFFECTS OF DIZOCILPINE (MK-801) ON THE FIRING ACTIVITY OF MIDBRAIN DOPAMINE NEURONES IN RATS CHRONICALLY TREATED WITH HALOPERIDOL AND D-SERINE.
A059.12. Poster board 509 - Sun 09/07, 16:45 - Hall Y
Hinterhoelzl J. (1), Salimi K. (1), Humpel C. (1), Adlassnig C. (1), Fischer-Colbrie R. (2), Fleischhacker W. W. (1) & Marksteiner J. (1)
(1) Dept. of Psychiatry, Innsbruck Med. Univ., Innsbruck, Austria; (2) Dept. of Pharmacology, Innsbruck Med. Univ., Innsbruck, Austria
- DIFFERENTIAL EFFECTS OF PHENCYCLIDINE APPLICATION ON SECRETOGRANIN II EXPRESSION IN ORGANOTYPIC SLICES OF RAT PREFRONTAL CORTEX.
A059.13. Poster board 510 - Sun 09/07, 16:00 - Hall Y
Kandler S. (1, 2), Reinartz S. (1) & Egert U. (1, 2)
(1) Neurobiol. Biophysics, Inst. Biol. III, Univ. Freiburg, Freiburg, Germany; (2) Bernstein Center for Comp. Neurosci., Univ. Freiburg, Freiburg, Germany
- DIFFERENTIAL CLASSIFICATION OF DOPAMINE RECEPTOR LIGANDS BASED ON CEREBELLAR SPIKE ACTIVITY IN VITRO.
A059.14. Poster board 511 - Sun 09/07, 16:45 - Hall Y
Kleefstra A. J. (1), Lewis L. (2), Vd Kooij M. (3), Hamelink R. (1), Tros R. (1), Leguit N. (1), McCreary A. C. (1) & Glennon J. C. (1)
(1) Solvay Pharmaceuticals, Weesp, Netherlands; (2) University of Bath, Bath, United Kingdom; (3) University of Leiden, Leiden, Netherlands
- REVERSAL OF PHENCYCLIDINE STIMULATED BASOLATERAL AMYGDALA DOPAMINE AND NORADRENALINE RELEASE BY ARIPIPRAZOLE BUT NOT CLOZAPINE AND HALOPERIDOL INVOLVES DOPAMINE D2 AND SEROTONIN 5-HT1A RECEPTORS.
A059.15. Poster board 512 - Sun 09/07, 16:00 - Hall Y
Knight H. M. (1, 2), Ayub M. (3), Maclean A. (2), Pickard B. S. (2), Muir W. J. (1) & Blackwood D. H. (1)
(1) Psychiatry, Edinburgh, United Knigdom; (2) Medical Genetics, Edinburgh, United Kingdom; (3) Psychiatry, St Luke's Hospital, Middlesbrough, United Kingdom
- HOMOZYGOSITY MAPPING IN A CONSANGUINEOUS FAMILY WITH SCHIZOPHRENIA CO-MORBID WITH EPILEPSY AND DEAFNESS.
A059.16. Poster board 513 - Sun 09/07, 16:45 - Hall Y
Lanza M., Chiusaroli R., Espinoza S. & Caselli G.
Rotta Research Laboratorium, R&D Division of ROTTAPHARM SpA, Monza (mi), Italy
- EFFECT OF NEBOGLAMINE ON FOS INDUCTION PATTERN IN THE RAT FOREBRAIN: COMPARISON WITH CLOZAPINE AND HALOPERIDOL.
A059.17. Poster board 514 - Sun 09/07, 16:00 - Hall Y
Lavoie S., Steullet P., Cuénod M. & Do K. Q.
Center for Psychiatric Neurosciences, Lausanne, Switzerland
- GLUTATHIONE DEFICIT IN SCHIZOPHRENIA: REPLENISHMENT OF GLUTATHIONE LEVELS IN NEURONS AND ASTROCYTES MODELS.
A059.18. Poster board 515 - Sun 09/07, 16:45 - Hall Y
Marquet A. (1, 3), Morris B. J. (1, 3), Pratt J. A. (2, 3) & Winchester C. L. (2, 3)
(1) Inst. of Biomed. and Life Sci., University of Glasgow, Glasgow, UK; (2) Dept of Physiology and Pharmacol., University of Strathclyde, Glasgow, UK; (3) Yoshitomi Res. Inst. of Neurosci. in Glasgow, Glasgow, UK
- ANOTHER GENE FOR SCHIZOPHRENIA ?
A059.19. Poster board 516 - Sun 09/07, 16:00 - Hall Y
Martel J. C. (1), Leduc N. (1), Ormiere A. M. (1), Assie M. B. (1), Cussac D. (2) & Newman-Tancredi A. (1)
(1) Div. of Neurobiology 2, Castres, France; (2) Dept. of Cellular and Molecular Biology, Castres, France
- F15063, AN INNOVATIVE ANTIPSYCHOTIC WITH POTENT D2/D3 ANTAGONIST, 5-HT1A AND D4 AGONIST PROPERTIES: IN VITRO PHARMACOLOGICAL PROFILE AND FUNCTIONAL AUTORADIOGRAPHY IN RAT BRAIN.
A059.20. Poster board 517 - Sun 09/07, 16:45 - Hall Y
Melendez-Ferro M., Perez-Costas E. & Roberts R. C.
MPRC, Dept. Psych, University of Maryland School of Medicine, Baltimore, USA
- GOLGI STAINING OF LONG-TERM STORED HUMAN BRAIN TISSUE.
A059.21. Poster board 518 - Sun 09/07, 16:00 - Hall Y
Perez-Costas E., Guidetti P., Kelley J. J., Melendez-Ferro M. & Roberts R. C.
MPRC Dept. Psych., University of Maryland School of Medicine, Baltimore, USA
- FEASIBILITY OF ANTIPSYCHOTIC ORAL TREATMENTS IN ANIMAL MODELS MONITORED BY PLASMA LEVELS AND RECEPTOR OCCUPANCY ASSAYS.
A059.22. Poster board 519 - Sun 09/07, 16:45 - Hall Y
Preissmann D. (1, 2, 3), Cocchi L. (1, 2, 3, 4), Do K. Q. (3), Vianin P. (5) & Schenk F. (1, 2, 3)
(1) Dep. Physiol., Lausanne, Switzerland; (2) Inst. of Psychology, Lausanne, Switzerland; (3) Cent. of Psychiatr. Neurosci., Lausanne, Switzerland; (4) Inst. Scienc. Sports et de l'Educ., Lausanne, Switzerland; (5) Dep. Univ. Psychiatry adulte, Lausanne, Switzerland
- WORKING MEMORY PROCESSING IN SCHIZOPHRENIA: HUMAN AND ANIMAL MODEL COHERENCE.
A059.23. Poster board 520 - Sun 09/07, 16:00 - Hall Y
Racca C. (1), Hunt J. (1), Middleton S. (1), Lebeau F. E. N. (1), Gillies M. G. (1), Davies C. H. (2), Maycox P. R. (2), Whittington M. A. (1) & Cunningham M. O. (1).
(1) Sch. Neurol., Neurobiol. & Psych., Univ. Newcastle, Newcastle Upon Tyne, UK; (2) Psychiatry CEDD, GlaxoSmithkline plc, Harlow, UK
- REGION-SPECIFIC REDUCTION IN ENTORHINAL GAMMA OSCILLATIONS AND PARVALBUMIN IMMUNOREACTIVE NEURONS IN ANIMAL MODELS OF PSYCHIATRIC ILLNESS.
A059.24. Poster board 521 - Sun 09/07, 16:45 - Hall Y
Sandager Nielsen K. (1), Scheel-Kruger J. (1), Fattorusso C. (3), Butini S. (2) & Campiani G. (2)
(1) CNS pharmacology, NeuroSearch, Ballerup, Denmark; (2) Dipartimento Farmaco Chimico Tecnologico, Siena, Italy; (3) Dipartimento di Chimica delle Sostanze Naturali, Napoli, Italy
- CAM17, A D3 RECEPTOR ANTAGONIST, IS EFFECTIVE IN ANIMAL MODELS OF PSYCHOSIS WITHOUT EXTRAPYRAMIDAL SIDE EFFECTS.
A059.25. Poster board 522 - Sun 09/07, 16:00 - Hall Y
Schiffelholz T. (1), Blume A. (2), Marx A. (1), Fritzer G. (1) & Aldenhoff J. (1)
(1) ZiP gGmbH, Kiel, Germany; (2) Insitute of Zoology, Regensburg, Germany
- EARLY POSTNATAL MK-801 TREATMENT AFFECTS AGE-RELATED CHANGES IN BEHAVIOUR FROM CHILDHOOD TO LATER ADULTHOOD IN RATS.
A059.26. Poster board 523 - Sun 09/07, 16:45 - Hall Y
Schlagenhauf F. (1), Juckel G. (1, 3), Koslowski M. (1), Filonov D. (1), Wüstenberg T. (2, 4), Villringer A. (2), Knutson B. (5), Kienast T. (1), Gallinat J. (1), Wrase J. (1) & Heinz A. (1)
(1) Department of Psychiatry, Charité Universitätsmedizin, CCM, Berlin, Germany; (2) Department of Neurology, Charité Universitätsmedizin, CCM, Berlin, Germany; (3) Department of Psychiatry, Ruhr-University Bochum, Bochum, Germany; (4) Department of Medical Psychology, Georg August University, Göttingen, Germany; (5) Department of Psychology, Stanford University, Stanford, USA
- DYSFUNCTION OF VENTRAL STRIATAL REWARD PREDICTION IN SCHIZOPHRENIC PATIENTS TREATED WITH TYPICAL BUT NOT ATYPICAL NEUROLEPTICS.
A059.27. Poster board 524 - Sun 09/07, 16:00 - Hall Y
Selch S., Fritzen S., Finger M., Schmitt A. G., Lesch K. P. & Reif A.
Dept. of Psychiatry, University of Wuerzburg, Wuerzburg, Germany
- NEURAL STEM CELL PROLIFERATION IS SIGNIFICANTLY REDUCED IN SCHIZOPHRENIC, BUT NOT AFFECTIVE PSYCHOSES.
A059.28. Poster board 525 - Sun 09/07, 16:45 - Hall Y
Sharma R. P., Rosen C., Kartan S., Grayson D. & Chase K.
University of Illinois, Chicago, USA
- VALPROIC ACID AND CHROMATIN REMODELING IN SCHIZOPHRENIA AND BIPOLAR DISORDER: PRELIMINARY RESULTS FROM A CLINICAL POPULATION.
A059.29. Poster board 526 - Sun 09/07, 16:00 - Hall Y
Sziráki I. L., Andrási F., Berzsenyi P., Horváth K., Király I. & Bagdy E.
Institute for Drug Research, Budapest, Hungary
- FURTHER NEUROCHEMICAL CHARACTERIZATION OF GYKI-52322, AN ATYPICAL ANTIPSYCHOTIC.
A059.30. Poster board 527 - Sun 09/07, 16:45 - Hall Y
Yee B. K. (1), Meyer U. (1), Nyffeler M. (1), Knuesel I. (1), Schedlowski M. (2) & Feldon J. (1)
(1) Lab Behav Neurobiol, ETH Zurich, Schwerzenbach, Switzerland; (2) Lab Psych & Behav Immunology, ETH Zurich, Zurich, Switzerland
- MODELLING AN EPIDEMIOLOGICAL LINK IN SCHIZOPHRENIA AND RELATED DISORDERS IN ANIMALS: FROM PRENATAL IMMUNE CHALLENGE TO ADULT PSYCHOPATHOLOGY AND NEUROPATHOLOGY.